164 related articles for article (PubMed ID: 34001936)
1. The implication of autoantibodies in early diagnosis and monitoring of plasmonic photothermal therapy in the treatment of feline mammary carcinoma.
El-Rasikh AM; Farghali HAM; Abdelrahman HA; Elgaffary M; Abdelmalek S; Emam IA; Ghoneim MA; Selim SA
Sci Rep; 2021 May; 11(1):10441. PubMed ID: 34001936
[TBL] [Abstract][Full Text] [Related]
2. Immunological aspects of mammary tumors in dogs and cats: a survey including own studies and pertinent literature.
Rutten VP; Misdorp W; Gauthier A; Estrada M; Mialot JP; Parodi AL; Rutteman GR; Weyer K
Vet Immunol Immunopathol; 1990 Nov; 26(3):211-25. PubMed ID: 2264285
[TBL] [Abstract][Full Text] [Related]
3. Early detection, aggressive therapy: optimizing the management of feline mammary masses.
Giménez F; Hecht S; Craig LE; Legendre AM
J Feline Med Surg; 2010 Mar; 12(3):214-24. PubMed ID: 20193912
[TBL] [Abstract][Full Text] [Related]
4. Treatment of natural mammary gland tumors in canines and felines using gold nanorods-assisted plasmonic photothermal therapy to induce tumor apoptosis.
Ali MR; Ibrahim IM; Ali HR; Selim SA; El-Sayed MA
Int J Nanomedicine; 2016; 11():4849-4863. PubMed ID: 27703351
[TBL] [Abstract][Full Text] [Related]
5. Serum proteomics analysis of feline mammary carcinoma based on label-free and PRM techniques.
Zheng JS; Wei RY; Wang Z; Zhu TT; Ruan HR; Wei X; Hou KW; Wu R
J Vet Sci; 2020 May; 21(3):e45. PubMed ID: 32476319
[TBL] [Abstract][Full Text] [Related]
6. Clinical, cytological and histopathological evaluation of mammary masses in cats from Rio de Janeiro, Brazil.
Amorim FV; Souza HJ; Ferreira AM; Fonseca AB
J Feline Med Surg; 2006 Dec; 8(6):379-88. PubMed ID: 16815063
[TBL] [Abstract][Full Text] [Related]
7. Histologic evaluation of Ki-67 and cleaved caspase-3 expression in feline mammary carcinoma.
Silva MN; Leite JS; Mello MF; Silva KV; Corgozinho KB; de Souza HJ; Cunha SC; Ferreira AM
J Feline Med Surg; 2017 Apr; 19(4):440-445. PubMed ID: 26917536
[TBL] [Abstract][Full Text] [Related]
8. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours.
Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R
Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis.
Mills SW; Musil KM; Davies JL; Hendrick S; Duncan C; Jackson ML; Kidney B; Philibert H; Wobeser BK; Simko E
Vet Pathol; 2015 Mar; 52(2):238-49. PubMed ID: 25060990
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors.
Marques CS; Santos AR; Gameiro A; Correia J; Ferreira F
BMC Cancer; 2018 Jul; 18(1):741. PubMed ID: 30012106
[TBL] [Abstract][Full Text] [Related]
11. Detection of tumor-associated antigens in sera of canine cancer patients by monoclonal antibodies generated against canine mammary carcinoma cells.
Wang J; Brunner CJ; Gangopadhyay A; Bird AC; Wolfe LG
Vet Immunol Immunopathol; 1995 Oct; 48(3-4):193-207. PubMed ID: 8578680
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of mammary carcinoma in male cats.
Skorupski KA; Overley B; Shofer FS; Goldschmidt MH; Miller CA; Sørenmo KU
J Vet Intern Med; 2005; 19(1):52-5. PubMed ID: 15715048
[TBL] [Abstract][Full Text] [Related]
13. Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status.
Soares M; Ribeiro R; Najmudin S; Gameiro A; Rodrigues R; Cardoso F; Ferreira F
Oncotarget; 2016 Apr; 7(14):17314-26. PubMed ID: 26909614
[TBL] [Abstract][Full Text] [Related]
14. High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes.
Luo R; Zheng C; Song W; Tan Q; Shi Y; Han X
Cancer Sci; 2022 Feb; 113(2):770-783. PubMed ID: 34843149
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio is an independent prognostic marker for feline mammary carcinomas.
Petrucci GN; Lobo L; Queiroga F; Martins J; Prada J; Pires I; Henriques J
Vet Comp Oncol; 2021 Sep; 19(3):482-491. PubMed ID: 33576562
[TBL] [Abstract][Full Text] [Related]
16. Comparative value of clinical, cytological, and histopathological features in feline mammary gland tumors; an experimental model for the study of human breast cancer.
Shafiee R; Javanbakht J; Atyabi N; Bahrami A; Kheradmand D; Safaei R; Khadivar F; Hosseini E
Diagn Pathol; 2013 Aug; 8():136. PubMed ID: 23941603
[TBL] [Abstract][Full Text] [Related]
17. Nuclear cytomorphometry in feline mammary gland epithelial tumours.
Simeonov R; Simeonova G
Vet J; 2009 Feb; 179(2):296-300. PubMed ID: 17959399
[TBL] [Abstract][Full Text] [Related]
18. Pathological and Immunohistochemical Microscopy of Natural Cases of Canine and Feline Neoplastic Mammary Lesions.
Tawfik MF; Oda SS; Khafaga AF
Microsc Microanal; 2021 Aug; 27(4):910-922. PubMed ID: 34128458
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats.
Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
J Vet Med Sci; 2000 Jul; 62(7):743-50. PubMed ID: 10945293
[TBL] [Abstract][Full Text] [Related]
20. Principles of treatment for mammary gland tumors.
Novosad CA
Clin Tech Small Anim Pract; 2003 May; 18(2):107-9. PubMed ID: 12831071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
